Stay updated with breaking news from Lance alstodt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioRestorative Therapies Inc (NASDAQ: BRTX) has entered into a supply agreement with Evolutionary Biologics, a supplier of biologic-based cosmetics.
BioRestorative Therapies Announces Activation of Northwell Health in the Company's Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.
Long Island's highest paid executives newsday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.com Daily Mail and Mail on Sunday newspapers.
BioRestorative Therapies Gains Additional Investor Confidence As Insider Dale Broadrick, CEO Lance Alstodt Purchase Thousands of Shares pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
BioRestorative Therapies Gains Additional Investor Confidence As Insider Dale Broadrick, CEO Lance Alstodt Purchase Thousands of Shares saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Valuations, competitive landscape and market opportunity are fundamental characteristics in evaluating investment decisions. Insider buying – the “smart money” – can also be an indicator to evaluate the potential performance of a company.
BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) CEO Lance Alstodt acquired 4,200 shares of the company’s stock in a transaction on Tuesday, July 25th. The shares were purchased at an average cost of $2.44 per share, with a total value of $10,248.00. Following the completion of the purchase, the chief executive officer now directly […]
BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) CEO Lance Alstodt purchased 4,200 shares of BioRestorative Therapies stock in a transaction on Tuesday, July 25th. The stock was bought at an average cost of $2.44 per share, with a total value of $10,248.00. Following the transaction, the chief executive officer now directly owns 184,418 shares […]